Trials
Search / Trial NCT05643378

Role and Outcome of Endovascular Revascularization of Chronic Limb Ischaemia

Launched by MAHMOUD ABDELMOHSEN MOSTAFA OSMAN · Dec 7, 2022

Trial Information

Current as of February 05, 2025

Unknown status

Keywords

ClinConnect Summary

patients with chronic kidney diseases are at higher risk of developing peripheral artery diseases needing revascularization of diseased arteries via endovascular transluminal angioplasty

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • all patients with chronic kidney diseases on medical treatment or on dialysis and have critical limb ischaemia
  • Exclusion Criteria:
  • patients with acute renal failure and lower limb ischaemia.
  • chronic kidney diseased patients underwent previous intervention or surgery for lower limb ischaemia.
  • patients presented with acute limb ischaemia

About Mahmoud Abdelmohsen Mostafa Osman

Mahmoud Abdelmohsen Mostafa Osman is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, he actively oversees the design, implementation, and management of clinical trials that adhere to the highest ethical and regulatory standards. His expertise spans various therapeutic areas, and he collaborates with multidisciplinary teams to ensure rigorous scientific methodology and data integrity. Through his leadership, Mahmoud strives to facilitate the development of safe and effective treatments that address unmet medical needs.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials